An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia May 2024 24(5):298-304 - Subject
- Language
- ISSN
- 2152-2650